Pulmonary Disease, Chronic Obstructive  >>  Flutiform (fluticasone/formoterol)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Flutiform (fluticasone/formoterol) / Kyorin, Mundipharma, Vectura, Sanofi
NCT01946620 / 2012-004162-17: A Study to Show That Flutiform is Well Tolerated and Effective in the Treatment of COPD

Completed
3
1767
Europe, RoW
Flutiform, Formoterol
Mundipharma Research Limited
Chronic Obstructive Pulmonary Disease
04/16
05/16
NCT02195375: Flutiform® Compared With Seretide® in the Treatment of COPD

Completed
2/3
923
RoW
Flutiform 500/20 µg BID, Flutiform 250/10 µg BID, Seretide Accuhaler 50/500 µg BID
Mundipharma Research Limited
Chronic Obstructive Pulmonary Disease
05/16
05/16

Download Options